Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
CMC
Sort By
Newest First
1 / 3
1 / 3
PPQ
Fast Path to Market: Going from GMP1 to PPQ in Just 12 Months
Jessica Feldman, Ph.D.; Henning Gerschewski
Rentschler Biopharma SE
PAO-10-24-CL-12
Dec 02, 2024
CDMO
Revolutionary CDMO Wheeler Bio Appoints Patrick Lucy as CEO
David Alvaro, Ph.D.
Pharma's Almanac
PAO-10-24-CL-08
Oct 11, 2024
Developability
Mitigating Early Development Risks with Samsung Biologics DEVELOPICK™ Platform
Heonchang Lim
Samsung Biologics
PAO-09-24-CL-04
Sep 04, 2024
Digitalization
Radical Bioprocessing Efficiencies and Cost Reductions — The Next Wave of Biopharmaceutical Innovation
Michael Sokolov, Ph.D.
DataHow
PAO-08-24-CL-02
Aug 26, 2024
IND Enablement
IND Enablement and Drug Product Development – Mitigating Risk and Accelerating through the "Valley of Death"
Johannes Clemens
Coriolis Pharma
PAO-08-24-CL-07
Aug 16, 2024
CDMO Model
Rethinking the Conventional CDMO Model
Wheeler Bio
PAO-08-24-CL-04
Jul 29, 2024
AAV
Overcoming Variability and Scaling Challenges in AAV Manufacturing
Rafal Garus
Viralgen Vector Core
PAO-08-24-CL-03
Jul 22, 2024
Training
Biotech Training is a Challenge
April Stanley, MS MBA; Koey Keylon
Nice Insight
PAO-06-24-NI-01
Jun 11, 2024
Leap-In Transposase
Leveraging Innovative Transposase Technology for a Highly Reliable and Productive CMC Platform
Wheeler Bio
PAO-06-24-CL-05
May 30, 2024
The PHASE Platform
How Synergistic Collaborations Between Outsourcing Partners Can Accelerate Clinical Success
Wheeler Bio
PAO-05-24-CL-01
May 08, 2024
Advanceability
Right from the Start: Designing Advanceable Formulations and Processes at Phase I
Serán Bioscience
PAO-02-24-CL-09
Feb 26, 2024
CMC
Revolutionizing Early-Stage Biopharma Development: Introducing Wheeler Bio's Portable CMC® Platform
Wheeler Bio
PAO-12-23-CL-04
Feb 08, 2024
Drug Development
Podcast: Insights from CDO Experts from Samsung Biologics
Jiyeon Lee; Hyelyoung Jang
Samsung Biologics
POD-01-24-CL-01
Jan 16, 2024
Glycosylation
S-Glyn™ : Optimizing N-Glycan Profiles and their Effector Functions Using a Design-of-Experiments Approach
Junyong Park
Samsung Biologics
PAO-12-23-CL-06
Dec 14, 2023
Stem Cell Therapy
Designing A Recipe for Stem Cell Therapy Success
Ben Josey, Ph.D.; Robert Padilla
Corning Life Sciences
PTV-12-23-CL-01
Dec 12, 2023
Cell and Gene Therapy
Scaling Cell and Gene Therapy Processes from R&D to Production
Shawn Bates; Antonio Fernandez-Perez, Ph.D.
Corning Life Sciences
PAO-12-23-CL-03
Dec 12, 2023
Cell Culture Media
Market Trends Driving the Embrace of Plant-Based Cell-Culture Media Ingredients
Chris Wiedel
Nu-Tek BioSciences
PAO-10-23-CL-01
Dec 06, 2023
Cell Culture Media
Enabling Controlled End-to-End Biomanufacturing with Animal-Free Culture Media Products
Thomas Yezzi
Nu-Tek BioSciences
PAO-08-23-CL-05
Nov 14, 2023
Alloy Therapeutics and Wheeler Bio Announce Preferred Service Offering for Alloy Partners to Accelerate the Translation from Discovery to CMC
Wheeler Bio
PR-M11-23-01
Nov 08, 2023
Strategic Partnership
Samsung Biologics and Kurma Partners Announce Strategic Partnership for Development and Manufacturing of Biologics for Kurma’s Portfolio Companies
Samsung Biologics
PR-M10-23-06
Oct 24, 2023
